Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Morphine + normal saline refers to a specific analgesic regimen used in a clinical trial at Tel-Aviv Sourasky Medical Center for the management of postoperative pain. The protocol involves the epidural administration of morphine sulfate and normal saline at distinct time points (pre-incisional and post-incisional) to investigate the effects of preemptive analgesia in patients undergoing open colectomy. Morphine acts as a potent agonist of the mu-opioid receptor in the central nervous system, inhibiting ascending pain pathways and altering the perception of pain. This investigational use aims to optimize the timing of opioid administration to reduce overall postoperative pain scores and the consumption of supplemental analgesics like intravenous patient-controlled analgesia (IV-PCA) morphine. The normal saline component serves as a volume control or placebo in the crossover-style timing study.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on morphine + normal saline.